KUALA LUMPUR, June 23 — National Cancer Society Malaysia director Dr Murallitharan Munisamy said the ongoing drug shortage was affecting cancer treatment in the country, urging the government to be proactive and consider manufacturing critical medicines locally.
“Pharmaceutical companies would have tendered to the government at a certain price but because the tendered price and the price now may be different due to the fluctuation of ringgit to US dollar. So, some companies could be at a loss here. Malaysia also needed to be more responsive to the matter as lockdowns in China and India that were major producers of medicines and active ingredients meant the problem was likely to persist, he added.
Malaysia should have already learned the importance of self sufficiency from the Covid-19 pandemic when the world “held us hostage for Covid-19 vaccines”, he added.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: staronline - 🏆 4. / 75 Read more »
Source: staronline - 🏆 4. / 75 Read more »
Source: malaymail - 🏆 1. / 86 Read more »
Source: staronline - 🏆 4. / 75 Read more »